@article{NashBehrensOrbaietal.2018,
  author    = {Peter Nash and Frank Behrens and Ana-Maria Orbai and Suchitrita S. Rathmann and David H. Adams and Olivier Benichou and Atul Deodhar},
  title     = {Ixekizumab is efficacious when used alone or when added to conventional synthetic disease-modifying antirheumatic drugs (cDMARDs) in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor inhibitors},
  journal   = {RMD Open},
  volume    = {4},
  number    = {2, e000692},
  pages     = {1 -- 10},
  doi       = {10.1136/rmdopen-2018-000692},
  year      = {2018},
}